Competitive intelligence in life sciences is increasingly driven by fast-moving regulatory decisions (approvals, label changes, safety communications) and the underlying clinical evidence that supports them.
Teams need to quickly retrieve and screen competitor approvals and clinical activities by indication or molecule, extract what truly matters (endpoints, populations, comparators, safety language), and translate it into actionable strategy.
Because insights must be grounded and comparable to your existing evidence packs, manual workflows become slow, inconsistent, and hard to scale across therapeutic areas.
10× faster competitor decision reviews
Produce structured indication-level competitor reviews faster by extracting evidence from approvals, labels, review rationales, and supporting regulatory documents.
2× broader decision coverage
Scale coverage across more indications, molecules, labels, decisions, geographies, and approval contexts with standardized screening and extraction logic.
Comparable regulatory insights
Build comparable insight tables covering endpoints, populations, comparators, safety language, restrictions, differentiators, and review rationales — all linked to source evidence.
How it works
1
Retrieve competitor regulatory decisions - query FDA (and other authorities if relevant) by indication, molecule, or competitor to collect approvals, labels, reviews, and supporting documents into a structured corpus.
2
Screen and curate the most relevant set - apply inclusion criteria (population, line of therapy, comparator, endpoints, geography, date) to build a focused, decision-ready collection.
3
Extract key insights and decision drivers - capture structured fields (trial design, endpoints, effect sizes, safety language, subgroups, limitations) and the rationale behind approval decisions, with source-linked traceability.
4
Compare against your evidence packs - confront competitor decisions with your internal evidence base to highlight gaps, differentiators, and positioning options; generate a concise insight brief using your templates.
Regulatory-decision intelligence: structure approvals, labels, review rationales, endpoints, safety language, and decision drivers into reusable competitor evidence.
Evidence-pack confrontation: compare competitor decisions against your internal evidence packs to identify gaps, differentiators, and positioning opportunities.